Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bioshares Biotech Clinical Trial (BBC)

Bioshares Biotech Clinical Trial (BBC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BioShares
  • Assets Under Management 46,552,000
  • Market Capitalization, $K 46,552
  • Shares Outstanding, K 1,150
  • 60-Month Beta 1.67
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.30 (0.73%)
  • Most Recent Dividend 0.297 on 12/20/17
  • Management Fee 0.79%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.82 +10.24%
on 05/06/20
44.20 -8.17%
on 05/26/20
+3.82 (+10.39%)
since 05/05/20
3-Month
23.00 +76.48%
on 03/18/20
44.20 -8.17%
on 05/26/20
+4.32 (+11.91%)
since 03/05/20
52-Week
22.92 +77.09%
on 10/09/19
44.20 -8.17%
on 05/26/20
+13.58 (+50.25%)
since 06/05/19

Most Recent Stories

More News
4 Best ETF Charts of Q1 Earnings

Below are four ETFs that buoyed up on strong earnings results.

MSFT : 187.20 (+2.34%)
IBM : 132.06 (+2.46%)
AMZN : 2,483.00 (+0.91%)
SPY : 319.34 (+2.56%)
GOOGL : 1,440.02 (+1.82%)
ITB : 46.19 (+4.30%)
IBUY : 68.70 (+1.49%)
BBC : 40.59 (+0.30%)
WCLD : 34.86 (-0.60%)
Race for Coronavirus Vaccine Heats Up: Biotech ETFs to Gain

The COVID-19 pandemic has kept biotech players all over the world on their toes for a vaccine. This new opportunity has made the sector the most attractive one to investors.

JNJ : 147.30 (+0.39%)
SNY : 50.10 (+0.30%)
PFE : 35.99 (-0.06%)
MRK : 82.26 (+0.87%)
MRNA : 58.19 (-3.96%)
GSK : 41.70 (+0.12%)
NVAX : 46.30 (+3.67%)
IBB : 131.35 (-0.07%)
XBI : 102.91 (+0.81%)
BBH : 156.94 (-0.35%)
BBC : 40.59 (+0.30%)
ARKG : 44.88 (-0.63%)
BNTX : 49.18 (-1.64%)
GNOM : 16.44 (+0.18%)
Biotech ETF (BBC) Hits a New 52-Week High

This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?

MRK : 82.26 (+0.87%)
NVAX : 46.30 (+3.67%)
BBC : 40.59 (+0.30%)
Stocks & ETFs Beneficiaries of Coronavirus Vaccine Ramp-Up

Efforts in formulating a coronavirus vaccine are heating up. These stocks and ETFs look to be the largest beneficiaries.

AZN : 53.85 (-0.04%)
MRNA : 58.19 (-3.96%)
GSK : 41.70 (+0.12%)
NVAX : 46.30 (+3.67%)
CNCR : 25.84 (-0.83%)
INO : 11.93 (+0.42%)
PTH : 110.76 (+0.97%)
BBC : 40.59 (+0.30%)
BTEC : 41.91 (+1.23%)
ARKG : 44.88 (-0.63%)
IDN : 7.14 (+8.02%)
VXRT : 2.42 (-7.63%)
GNOM : 16.44 (+0.18%)
Top ETF Areas of Last Week

Wall Street was upbeat last week, mainly driven by these ETF areas.

USO : 28.87 (+4.98%)
BNO : 11.01 (+5.97%)
UGA : 19.17 (+5.97%)
IBUY : 68.70 (+1.49%)
BBC : 40.59 (+0.30%)
ARGT : 24.17 (+2.11%)
AGT : 20.80 (+2.42%)
BUYZ : 31.93 (+1.13%)
WCLD : 34.86 (-0.60%)
5 Market-Beating Smart-Beta ETF Charts of 2019

These smart-beta ETFs beat the broader market with ease in 2019.

AMZN : 2,483.00 (+0.91%)
AAPL : 331.50 (+2.85%)
DIA : 271.54 (+3.12%)
FTXL : 44.75 (+2.77%)
QQQ : 239.69 (+1.98%)
BBC : 40.59 (+0.30%)
SPY : 319.34 (+2.56%)
QTUM : 30.78 (+1.79%)
GOAU : 18.59 (-2.41%)
Biotech Rally Sends Nasdaq to 9000: ETFs in Focus

Some biotech stocks have contributed materially to the Nasdaq's 1000-point gain since Aug 27, 2018 and helped it notch a record 9,000 on Dec 26.

CSCO : 47.83 (+2.07%)
AMZN : 2,483.00 (+0.91%)
FB : 230.77 (+1.98%)
GOOG : 1,438.39 (+1.86%)
AAPL : 331.50 (+2.85%)
MSFT : 187.20 (+2.34%)
BBC : 40.59 (+0.30%)
XPH : 43.26 (+0.53%)
AXSM : 77.38 (+3.89%)
INTC : 64.34 (+2.18%)
CNST : 37.39 (-0.35%)
SAVA : 2.59 (-2.63%)
KOD : 61.35 (-7.40%)
RCEL : 6.84 (+1.33%)
9 ETFs at the Forefront of 2019 Market Rally

As there have been winners in many corners of the space, we highlight nine ETFs from different zones that have outperformed so far this year. These are expected to continue outperforming, provided the...

PBW : 39.03 (+3.06%)
TAN : 35.56 (+2.86%)
SMH : 152.70 (+2.36%)
ITB : 46.19 (+4.30%)
BBC : 40.59 (+0.30%)
XLK : 101.41 (+2.63%)
GOAU : 18.59 (-2.41%)
QTUM : 30.78 (+1.79%)
SILJ : 11.33 (-2.66%)
Best & Worst ETFs of Fourth Quarter

Inside the top and worst-performing ETFs of the fourth quarter.

BBC : 40.59 (+0.30%)
JO : 31.61 (+1.97%)
PAK : 23.73 (+2.28%)
VXX : 29.17 (-5.42%)
PIN : 17.06 (+1.49%)
GAZ : 17.22 (-1.48%)
POTX : 11.98 (-0.50%)
CHIR : 17.10 (+2.21%)
4 Sector ETFs That Beat the Market in Q4

While Wall Street is surging this quarter, these sector ETFs offered even better performances to beat the market.

DIA : 271.54 (+3.12%)
SOXX : 272.21 (+2.45%)
IEZ : 10.69 (+10.78%)
BBC : 40.59 (+0.30%)
SMH : 152.70 (+2.36%)
PXJ : 3.02 (+9.82%)
SIL : 33.84 (-2.45%)
XSD : 115.27 (+2.58%)
SBIO : 41.00 (+0.89%)
XPH : 43.26 (+0.53%)
QQQ : 239.69 (+1.98%)
SPY : 319.34 (+2.56%)
GNOM : 16.44 (+0.18%)
SILJ : 11.33 (-2.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade BBC with:

Fund Summary

The BioShares Biotechnology Clinical Trials Fund seeks investment results that correspond to the performance of the BioShares Biotechnology Clinical Trials Index. Clinical Trials stage companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their...

See More

Key Turning Points

2nd Resistance Point 41.99
1st Resistance Point 41.29
Last Price 40.59
1st Support Level 40.17
2nd Support Level 39.75

See More

52-Week High 44.20
Last Price 40.59
Fibonacci 61.8% 36.07
Fibonacci 50% 33.56
Fibonacci 38.2% 31.05
52-Week Low 22.92

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar